Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine

Critical Reviews in Oncology/Hematology

Volumn 39, Issue 1-2, 2001, Pages 173-180

  Stein, Rhona ^a   Govindan, Serengulam V ^b   Chen, Susan ^a   Reed, Linda ^a   Spiegelman, Heidi ^a   Griffiths, Gary L ^b   Hansen, Hans J ^b   Goldenberg, David M ^b  

^a GARDEN STATE CANCER CENTER   (United States)

^b Immunomedics   (United States)

Author keywords

Lung cancer; Monoclonal antibodies; Radioiodine; Residualizing labels

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RS7; RADIOACTIVE IODINE; TOSYLCHLORAMIDE SODIUM; UNCLASSIFIED DRUG; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; RADIOIMMUNOTHERAPY; RADIOIODINATION; REMISSION; TOXICITY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG EVALUATION, PRECLINICAL; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 0034984880     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00106-8     Document Type: Conference Paper

References (26)

1. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides
2. Radionuclides for radioimmunotherapy
3. Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells
4. Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse
5. The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels
6. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors
7. Advantage of a residualizing iodine radiolabel for radioimmunotherapy of xenografts of human non-small cell carcinoma of the lung
8. Improving the tumor retention of radioiodinated antibody: arylcarbohydrate adducts
9. Tumor specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts
10. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate
11. Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22
12. The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody
13. Labeling of monoclonal antibodies with DTPA-appended radioiodinated peptides containing D-amino acids
14. Targeting human cancer xenografts with MAbs labeled using radioiodinated, DTPA appended, peptides
15. Characterization of cluster 13: the epithelial/carcinoma antigen recognized by MAb RS7
16. Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody
17. 131I-labeled monoclonal antibody RS7-3G11
18. Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft
19. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting
20. Solid phase peptide synthesis utilizing 9-fluorenylmethylcarbonyl amino acids
21. A method of trace iodination of proteins for immunologic studies
22. 90Yttrium-labeled complementarity-determining-region-grafted monoclonal antibodies for radioimmunotherapy: radiolabeling and animal biodistribution studies
23. Asymptotically efficient rank invariant test procedures (with discussion)
24. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts
25. The fate of antibodies bound to the surface of tumor cells in vitro